Cartistem is a stem cell therapy designed to repair knee cartilage. It is manufactured from mesenchymal stem cells, according to the report, and mixed with hyaluronan. The two-year study plans to enroll 12 participants.
Dr. Cole is the head of Rush's Cartilage Restoration Center.
More Articles on Orthopedic Surgery:
8 Ideas for Orthopedic Practices to Improve Their Bottom Line
102 Surgeons Focused on Spine Surgery
3B Orthopaedics Surgeons Join Aria Health
Dr. Brian Cole Leads 1st US Study of Stem Cell Treatment for Knee Cartilage DamageWritten by Laura Miller | Friday, 25 January 2013 09:13
Brian Cole, MD, an orthopedic surgeon at Rush University Medical Center, is the principle investigator on the first clinical study of Cartistem in the United States, according to a News-Medical report.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.
New from Becker's Orthopedic & Spine Review